An Act to clarify prescription monitoring program activities

HD 2220 requires the state's prescription monitoring program to exclude testosterone from its tracking system and delete all existing data on testosterone prescriptions. This means healthcare providers no longer need to report testosterone prescriptions to the program, and historical records of such prescriptions will be removed immediately upon the bill's passage. The bill directly affects prescribers (like doctors) and pharmacies that handle testosterone, which is commonly used for hormone therapy. The change applies specifically to testosterone, not other medications, and takes effect right away without requiring additional approval.